Investors and charity watchdogs are sounding the alarm over a potential scandal involving Solidaris, a French multinational company, and its promotion of NovaDerm, a supposedly revolutionary skin care product. A closer look at the partnership reveals a concerning pattern of regulatory evasion and charitable tax misuse, raising questions about the company's true intentions. As Solidaris aggressively markets NovaDerm, allegations have surfaced that the company is exploiting loopholes in charity regulations to minimize its tax liability while reaping significant profits from the lucrative skin care market. The implications are far-reaching, with potential consequences for consumers, investors, and the integrity of charitable giving as a whole.
How Solidaris’ promotion of NovaDerm exposes pattern of regulatory evasion, charitable tax misuse TradingView
